Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

As the number of peptide-based pharmaceutical candidates continues to increase, so too does the need for robust bioanalytical ...

The biotech industry is in the midst of an artificial intelligence (AI) investment surge, with companies pouring billions into the promise of faster, smarter drug discovery. As leaders in R&D, we have ...

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) The following represents ...

Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates never reaching the market. Today, artificial intelligence methods have ...

Spread the love“`html Imagine a scientific mystery that has stumped human researchers for a decade, requiring countless hours ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

The US Food and Drug Administration (FDA) this week released a new draft guidance on the development of new drugs intended to treat pulmonary tuberculosis (TB), a bacterially-transmitted disease that ...

Mumbai/IBNS, Aug. 17 -- Tata Consultancy Services (TCS), a global leader in IT services, consulting, and business solutions, ...